HR 5391
Protecting Patient Access to Cancer and Complex Therapies Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Protecting Patient Access to Cancer and Complex Therapies Act aims to lower the cost of expensive medications for Medicare beneficiaries. It establishes a system where drug manufacturers must provide rebates to the government for certain cancer and complex therapies priced at or above a ‘maximum fair price.’ The bill requires manufacturers to report detailed information to the government about drug sales and payments, and establishes a process for calculating and applying these rebates, ultimately impacting how Medicare pays for these medications.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Michael C. Burgess
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.